The Artificial Intelligence in Medicine (AIM) PhD track, newly developed by the Department of Biomedical Informatics (DBMI) at Harvard Medical School, will enable future academic, clinical, industry, and government leaders to rapidly transform patient care, improve health outcomes, and accelerate precision medicine by creating new AI technologies that reason across massive-scale biomedical data and knowledge.